Shanghai HeartCare Medical Technology Co., Ltd. logo

Shanghai HeartCare Medical Technology Co., Ltd. (6609)

Market Closed
7 Aug, 08:00
HKEX HKEX
49. 24
HKD
+1.36
+2.8404%
HKD
775.81M Market Cap
- P/E Ratio
- Div Yield
71,600 Volume
- Eps
47.88 HKD
Previous Close
Add Transaction
Day Range
48.6 50.7
Year Range
35 71.25
Want to track 6609 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6609 closed Friday higher at 49.24 HKD, an increase of 2.8404% from Thursday's close, completing a monthly increase of 17.2381% or 7.24 HKD. Over the past 12 months, 6609 stock lost -8.4758%.
6609 is not paying dividends to its shareholders.
The last earnings report, released on Mar 26, 2026, missed the consensus estimates by -1.64%. On average, the company has fell short of earnings expectations by -1.64%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on HKEX (HKD).

6609 Chart

People also search for

Viva Biotech Holdings
1.62 HKD
+4.1667%
Chaoju Eye Care Holdings Ltd.
2.58 HKD
-0.5769%
MicroTech Medical (Hangzhou) Co., Ltd.
7.3 HKD
+4.5845%
Town Health International Medical Group Ltd.
0.18 HKD
-10%
Perfect Medical Health Management Ltd.
1.44 HKD
-2.381%

Shanghai HeartCare Medical Technology Co., Ltd. (6609) FAQ

What is the stock price today?

The current price is 49.24 HKD.

On which exchange is it traded?

Shanghai HeartCare Medical Technology Co., Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 6609.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 775.81M.

Has Shanghai HeartCare Medical Technology Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Shanghai HeartCare Medical Technology Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Guohui Wang CEO
HKEX Exchange
CNE100004MN5 ISIN
China Country
341 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Shanghai HeartCare Medical Technology Corporation Limited is at the forefront of innovation in the field of neuro-interventional medical devices, focused on developing, manufacturing, and selling state-of-the-art products for the medical industry. Founded in 2016 and headquartered in Shanghai, the People's Republic of China, the company specializes in providing advanced solutions for the treatment and prevention of acute ischemic stroke, neurovascular stenosis, and hemorrhagic stroke. Through its dedication to research and development, Shanghai HeartCare Medical Technology Corporation Limited aims to improve patient outcomes and enhance the quality of life for those suffering from these critical conditions.

Products and Services

  • Ischemic Stroke Thrombectomy Devices

    These devices are engineered for the removal of clots from blocked brain arteries to restore blood flow in patients experiencing an acute ischemic stroke. Their innovative design and technology make them an effective solution for emergency stroke treatment.

  • Intracranial Stenosis Treatment

    Shanghai HeartCare provides advanced solutions for the treatment of intracranial arterial stenosis, a condition that leads to narrowed brain arteries, utilizing cutting-edge devices designed to widen the arterial passageways and enhance blood flow, thereby reducing the risk of stroke.

  • Flow Diverter

    The flow diverter device is aimed at treating patients with aneurysms by diverting blood flow away from the aneurysm sac, thus promoting aneurysm thrombosis while maintaining patency of the parent vessel. This minimizes the risk of rupture and subsequent hemorrhagic stroke.

  • Vascular Access Devices

    These devices facilitate access to the vascular system for the purpose of performing diagnostic or therapeutic procedures, including the deployment of stents or removal of blockages, paramount for effective treatment of various neurovascular conditions.

  • Neurovascular Stenosis Treatment

    Focused on combating neurovascular stenosis, the company offers a range of devices that alleviate this condition by widening narrow vascular passages in the brain, ensuring an unimpeded flow of blood, essential for the healthy functioning of brain tissues.

  • Hemorrhagic Stroke Treatment

    Shanghai HeartCare’s offerings in this category are designed to limit the damage caused by hemorrhagic strokes through innovative devices that prevent blood vessel rupture or manage its consequences, thereby saving lives and improving recovery outcomes.

  • Interventional Access

    The interventional access products provide medical professionals with the necessary tools to access areas of the body affected by neurovascular conditions, facilitating a wide range of interventions from diagnostics to treatment application, ensuring high precision and safety.

Contact Information

Address: Building 38
Phone: 86 21 3752 6556